FDA Drug Safety Board Meets
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA will post a summary of the inaugural meeting of its Drug Safety Oversight Board on its website on or around June 24, the agency said
You may also be interested in...
FDA Drug Safety Board To Meet Every Six Weeks
The board discussed FDA's recent action on fentanyl transdermal patches (J&J's Duragesic and generics) and Purdue's Palladone (hydromorphone extended-release) during a July 27 meeting, FDA's meeting summary says.
FDA Drug Safety Board To Meet Every Six Weeks
The board discussed FDA's recent action on fentanyl transdermal patches (J&J's Duragesic and generics) and Purdue's Palladone (hydromorphone extended-release) during a July 27 meeting, FDA's meeting summary says.
Drug Safety Oversight Board Proceedings Should Be More Open, Rep. DeLauro Says
FDA Commissioner Crawford defends the board as an "instrument of openness" in response to complaints that the panel's closed proceedings will fail to provide greater transparency.